HealthTech
Predicta Biosciences
Predicta Biosciences raises $23.4M Series A
$23.4M
Total Raised
Series A
Latest Round
2020
Founded
40+
Employees
Cambridge, MA
1 min read
Quick Facts
Latest Round Size
$23.4M
Latest Round Date
August 2025
Predicta Biosciences: Series A Funding Round
Predicta Biosciences has successfully raised $23.4M in Series A funding.
Company Overview
Precision medicine platform for predictive biomarker discovery
Funding Details
The Series A round was led by Engine Ventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2020
- Employees: 40+
- Category: HealthTech
Investment
Predicta Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Engine Ventures: Verified investor in Series A
Key Investors
Engine Ventures
Lead Investor
Verified investor in Series A
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
Zingage
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
Editorial Team
Oct 9, 2025
1 min read•$12.5M
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
Duos
Duos raises $130M Growth at $600M valuation
Duos raises $130M in Growth at $600M valuation. Digital health platform for Medicare beneficiaries...
Editorial Team
Oct 7, 2025
1 min read•$130M